v3.26.1
Condensed Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Jul. 31, 2026
Jul. 31, 2025
Cash flows from operating activities:    
Net loss $ (3,027,002) $ (2,702,684)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation expense 27,685 27,685
Stock-based compensation to employees, directors and consultants 77,199 42,902
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets 390,372 (79,239)
Accounts payable and accrued liabilities 1,393,229 348,550
Net cash used in operating activities (1,138,517) (2,362,786)
Cash flows from financing activities:    
Net proceeds from the issuance of common stock 669,272
Net proceeds from the issuance of preferred stock, net 7,350,000 4,035,000
Net cash provided by financing activities 8,019,272 4,035,000
Net increase in cash 6,880,755 1,672,214
Cash at beginning of period 710,689 3,948,658
Cash at end of period 7,591,444 5,620,872
Non-cash financing activities:    
Conversion of Series B convertible preferred stock to common stock 564,755
Conversion of Series C convertible preferred stock to common stock $ 5,757,176